Patterson Companies

Patterson Cos., Inc. provides products, technologies, services, and business solutions to the dental and animal health markets. It operates through the following segments: Dental, Animal Health, and Corporate. The Dental segment provides consumable dental products, equipment and software, turnkey digital solutions, and value-added services to dentists, dental laboratories, institutions, and other healthcare professionals. The Animal Health segment distributes animal health products, services, and technologies to both the production-animal and companion-pet markets. The Corporate segment consists of general and administrative expenses, including home office support costs in areas such as information technology, finance, legal, human resources, and facilities. The company was founded by John Patterson and Myron Fayette Patterson in 1877 and is headquartered in St. Paul, MN.

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Patterson Companies Inc. reports strong Q4 performance and outlines growth strategies for fiscal 2024

Patterson Companies Inc. delivered strong financial results for Q4 2023, with a focus on sustained margin improvement and strategic growth opportunities. Despite challenges in free cash flow and market moderation, the company is well-positioned to leverage its strengths and capitalize on opportunities in the dental and animal health segments.

Patterson Companies Inc. reports strong Q2 earnings and focuses on private label growth

Patterson Companies Inc. delivered strong financial performance in Q2 2023, driven by growth in both the Dental and Animal Health segments. The company reaffirmed fiscal '24 earnings guidance and highlighted the potential of private label products. Despite tax and interest rate challenges, the company remains optimistic and focused on strategic initiatives to drive future growth.

Patterson Companies excels in Q3, eyes international growth opportunities

Patterson Companies reported a strong Q3 performance with internal sales growth and margin improvements. Challenges in the Dental segment were offset by growth in the Animal Health segment. The company highlighted strategic acquisitions, leadership appointments, and operational enhancements as key drivers of success. Opportunities lie in stable patient traffic, international investments, and exploring M&A in dental specialties for future growth.

Patterson Companies reports strong Q4 performance and strategic growth focus

Patterson Companies had a robust Q4 performance, showcasing growth in sales and margins. Despite challenges in the companion animal market, the company is strategically positioned for growth through software investments and service enhancements. Opportunities lie in sustained sales growth, margin expansion, and strategic market positioning.

Patterson Companies reports strong Q1 results amidst strategic focus

Patterson Companies delivered strong Q1 '24 results with growth in sales and adjusted EPS. The company is strategically focusing on private label products and efficiency improvements. While facing challenges like deflationary impacts and inflationary pressures, Patterson sees opportunities in Dental equipment growth and continued investments for long-term profitability.

Patterson Companies reports strong Q2 performance amidst market challenges

Patterson Companies delivered a solid performance in Q2 2024, driven by growth in Dental and Animal Health segments.
Despite challenges like macroeconomic headwinds and pricing pressures, the company remains focused on efficiency and driving demand.
Opportunities exist for Patterson to capitalize on market trends, optimize operations, and explore new growth avenues.
Investors should monitor how Patterson navigates challenges and leverages strengths to achieve its revised fiscal guidance.

Patterson Companies reports solid Q3 performance amidst market challenges

Patterson Companies delivered a solid performance in Q3 2024, with a focus on revenue growth, margin expansion, and strategic investments in distribution and software offerings.
While facing challenges in certain segments, the company remains committed to operational efficiency, margin integrity, and long-term growth initiatives.
Opportunities lie in sustaining sales growth, expanding market presence, and capitalizing on improvements in equipment demand and margin enhancement.
Overall, Patterson's strategic focus on growth, efficiency, and innovation positions the company for long-term success in the market.

Patterson Companies Reports Stable Q4, Eyes Strategic Growth

Patterson Companies concluded fiscal 2024 with stable financial performance, facing some headwinds in the Dental segment but offset by gains in Animal Health and strategic tech investments. The company is poised for modest growth in 2025, backed by ongoing investments in high-margin areas and a strong focus on innovation and market expansion.

Patterson Companies addresses challenges in Q1 2025 earnings call

Patterson Companies faced challenges in Q1 2025, with declines in both the Dental and Animal Health segments.
Despite these challenges, management is taking actions to improve performance and profitability for the rest of fiscal 2025.
The company's focus on cost management and operational efficiency is a strength in navigating the current environment.
Opportunities exist in strengthening the companion animal business, improving internal sales, and enhancing cybersecurity measures.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Patterson Cos., Inc. engages in the provision of products, technologies, services, and business solutions to the dental and animal health markets. It operates through the following segments: Dental, Animal Health, and Corporate. The Dental segment provides consumable dental products, equipment and software, turnkey digital solutions, and value-added services to dentists, dental laboratories, institutions, and other healthcare professionals. The Animal Health segment distributes animal health products, services, and technologies to both the production-animal and companion-pet markets. The Corporate segment consists of general and administrative expenses, including home office support costs in areas such as information technology, finance, legal, human resources, and facilities. The company was founded by John Patterson and Myron Fayette Patterson in 1877 and is headquartered in St. Paul, MN.

Shares of Patterson Companies (NASDAQ:PDCO) were unchanged after the company reported Q3 results. Quarterly Results Earnings per share were up 23.40% year over year to $0.58, which beat the estimate of $0.51.

Recap: Patterson Companies Q3 Earnings

ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies, Inc. (Nasdaq: PDCO) today reported consolidated net sales of $1.55 billion (see attached Sales Summary for further details) in its fiscal third quarter ended January 23, 2021, an increase of 6.5 percent compared to the same period last year. Internal sales, which are adjusted for the effects of currency translation and changes in product selling relationships, increased 6.9 percent. Reported net income attributable to Patterson Companies, I

Patterson Companies Reports Fiscal 2021 Third-Quarter Operating Results

Patterson Companies (NASDAQ:PDCO) announces its next round of earnings this Wednesday, March 03. Here is Benzinga's everything-that-matters guide for this Wednesday's Q3 earnings announcement.

Patterson Companies Earnings Preview

ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies (Nasdaq: PDCO) today announced that it will hold its fiscal 2021 third-quarter conference call on Wednesday, March 3, 2021 at 9 a.m. CT (10 a.m. ET). The company's earnings release will be issued that morning before the market opens. To access the live webcast, go to the investor relations section of the company's website, www.PattersonCompanies.com. The third-quarter fiscal 2021 earnings conference call replay will be available beginning at

Patterson Companies Fiscal 2021 Third-Quarter Conference Call Scheduled for Wednesday, March 3, 2021

Patterson Cos. (PDCO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report.

Patterson Cos. (PDCO) to Report Q3 Results: Wall Street Expects Earnings Growth

Is (PDCO) Outperforming Other Medical Stocks This Year?

Is Patterson Companies (PDCO) Outperforming Other Medical Stocks This Year?

ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies, Inc., a distributor focused on providing the best products, technologies, services and business solutions to the animal and oral health markets, announced today that the company will virtually present at the 2021 J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021 at 5:20 p.m. Eastern Time. The conference brings together leaders from across the health care industry, emerging fast-growth companies and innovative technology leaders

Patterson Companies to Present at the 2021 J.P. Morgan Healthcare Conference

Patterson Companies' stock performed similar to the stocks of Bed Bath & Beyond, GameStop or Owens & Minor. Although the stock price increased 150% since April 2020, the fundamental business provides no reason to be so optimistic.

Patterson Companies: Fitting A Worrisome Pattern

Patterson Cos. (PDCO) reported earnings 30 days ago.

Patterson Cos. (PDCO) Down 7.4% Since Last Earnings Report: Can It Rebound?

Align Technology

West Pharmaceutical Services

Buy these three top dental stocks that have shown sharp recovery despite market volatility due to the pandemic, and have the potential to continue their bull run in 2021.

Grab 3 Dental Stocks More Than Doubling Industry Gains for 2021

PDCO vs. ALGN: Which Stock Is the Better Value Option?

PDCO or ALGN: Which Is the Better Value Stock Right Now?

Let's see if Patterson Companies (PDCO) stock is a good choice for value-oriented investors right now from multiple angles.

Should Value Investors Pick Patterson Companies (PDCO) Stock?

Patterson Cos. (PDCO) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Earnings Estimates Rising for Patterson Cos. (PDCO): Will It Gain?

STRATTEC SECURITY

Ultra Clean

Some stocks should move higher despite their recent rally.

3 High-Flying Stocks that Should Move Higher

Brooks Automation

Schnitzer Steel Industries

Top Ranked Momentum Stocks to Buy for December 4th

Patterson Companies, Inc. (PDCO) CEO Mark Walchirk on Q2 2021 Results - Earnings Call Transcript

Patterson Companies' (PDCO) fiscal second-quarter 2021 results benefit from strong segmental performance.

Patterson Companies (PDCO) Q2 Earnings Top Estimates, Up Y/Y

Patterson Cos. (PDCO) delivered earnings and revenue surprises of 65.79% and 8.81%, respectively, for the quarter ended October 2020.

Patterson Cos. (PDCO) Q2 Earnings and Revenues Top Estimates

Shares of Patterson Companies (NASDAQ:PDCO) moved higher by 0.1% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share increased 61.54% over the past year to $0.63, which beat the estimate of $0.38.

Recap: Patterson Companies Q2 Earnings

ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies, Inc. (Nasdaq: PDCO) today reported consolidated net sales of $1.55 billion (see attached Sales Summary for further details) in its fiscal second quarter ended October 24, 2020, an increase of 9.5 percent compared to the same period last year. Internal sales, which are adjusted for the effects of currency translation, increased 9.0 percent. Reported net income attributable to Patterson Companies, Inc. for the second quarter of fiscal 2021 wa

Patterson Companies Reports Fiscal 2021 Second-Quarter Operating Results

Merit Medical Systems

PDCO vs. MMSI: Which Stock Is the Better Value Option?

PDCO vs. MMSI: Which Stock Should Value Investors Buy Now?

ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies (Nasdaq: PDCO) today announced that it will hold its fiscal 2021 second-quarter conference call on Wednesday, December 2, 2020 at 9 a.m. CT (10 a.m. ET). The company's earnings release will be issued that morning before the market opens. To access the live webcast, go to the investor relations section of the company's website, www.PattersonCompanies.com. The second-quarter fiscal 2021 earnings conference call replay will be available beginni

News for Patterson Companies Stock (PDCO)